VivaBioCell. Next generation manufacturing
solutions for advanced therapies
NANT 001 System
Seamless transition from R&D to clinical and commercial manufacturing.
Automated cell expansion and harvest. Small- to mid-scale batch sizes.
Assuring product quality and minimizing costs.
Easier cGMP translation and shorter time to market.
The ideal solution for autologous products and redistributed scale-out manufacturing.
NANT 001 Cartridge
The components you already know.
Engineered in an easy-to-load, single-use, closed-system for safe and cGMP-compliant cell processing.
NANT 001 Bioreactor
Built-in microscope, confluence estimation and in-process controls.
High medicinal product standardization. Remote access for monitoring, always at your fingertips.
Latest News
VivaBioCell at ISCT EU 2018 Regional Meeting
Meet us at ISCT EU 2018 Regional Meeting, held in Florence, Italy on September 12-14, 2018! Come to booth #12 and talk to us to understand how the NANT 001 System can be integrated into your process. Read more ›
ARTE Project - Interreg V-A Italy-Slovenia 2014-2020
VivaBioCell is a beneficiary of ARTE (Advanced Regenerative Therapies Ecosystem), a project approved under the EC Interreg V-A Italia-Slovenia. According to the Europe 2020 Strategy, Interreg fosters cross-border cooperation investing significant resources in growth and innovation, quality of life and environmental sustainability. Read more ›
POR FESR 2014-2020 FVG: OPPORTUNITA' PER UNA CRESCITA SOSTENIBILE.
VivaBioCell is a beneficiary of SISICOR (Sistema Implantare per la Stabilità immediata di impianto in Chirurgia Orale di Ricostruzione), a project approved under the POR FESR 2014-2020 Friuli Venezia Giulia. Read more ›
© 2018 VivaBioCell S.p.A. a socio unico - via del Cotonificio, 127 - 33100 - Udine (UD) - Italy
P. IVA 02470470309 - R.E.A. UD-263358
Capitale sociale € 981.974,00 i.v.